NEWS
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
OptimizeRx Corp. (Nasdaq: OPRX) has expanded its strategic relationship with a major pharma client, resulting in a multi-solution, multi-brand program with a total in-year commitment of over $10 million. This includes the previously mentioned $6 million DAAP contract, which is still undergoing internal review. The expansion demonstrates the value of OptimizeRx's solutions in driving stronger commercial performance through HCP and DTC marketing alignment.
Key highlights:
Top 20 pharma clients now average $2.7 million in revenue per client
Top 3 clients contribute $9.7 million in revenue
Organic growth remains a key driver for the business
The company is leveraging its omni-channel platform powered by AI-targeted reach
Key highlights:
Top 20 pharma clients now average $2.7 million in revenue per client
Top 3 clients contribute $9.7 million in revenue
Organic growth remains a key driver for the business
The company is leveraging its omni-channel platform powered by AI-targeted reach
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment